blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4115901

EP4115901 - LIVE-PATHOGEN-MIMETIC NANOPARTICLES BASED ON PATHOGEN CELL WALL SKELETON, AND PRODUCTION METHOD THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  09.12.2022
Database last updated on 02.09.2024
FormerThe international publication has been made
Status updated on  10.09.2021
Most recent event   Tooltip12.03.2024Supplementary search reportpublished on 10.04.2024  [2024/15]
Applicant(s)For all designated states
PROGENEER INC.
1002, 12, Digital-ro 31-gil
Guro-gu
Seoul 08380 / KR
[2023/02]
Inventor(s)01 / LIM, Yong Taik
524-1301, 151, Naejeong-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13597 / KR
02 / LEE, Sang Nam
3-605, 24, Hwasan-ro 203beon-gil, Jangan-gu
Suwon-si, Gyeonggi-do 16417 / KR
 [2023/02]
Representative(s)Dehns
St. Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[2023/02]
Application number, filing date21765344.326.02.2021
[2023/02]
WO2021KR02508
Priority number, dateKR2020002578002.03.2020         Original published format: KR 20200025780
KR2021002601325.02.2021         Original published format: KR 20210026013
[2023/02]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021177679
Date:10.09.2021
Language:KO
[2021/36]
Type: A1 Application with search report 
No.:EP4115901
Date:11.01.2023
Language:EN
[2023/02]
Search report(s)International search report - published on:KR10.09.2021
(Supplementary) European search report - dispatched on:EP11.03.2024
ClassificationIPC:A61K39/39, A61K9/19, A61K39/00, A61K9/51
[2024/15]
CPC:
A61K39/39 (EP,US); A61K9/19 (US); A61K2039/55511 (EP);
A61K2039/55555 (US); A61K2039/55594 (EP)
Former IPC [2023/02]A61K39/39, A61K9/19, A61K39/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/02]
TitleGerman:LEBENDPATHOGENMIMETISCHE NANOPARTIKEL AUF BASIS EINES KRANKHEITSERREGERZELLWANDSKELETTS UND HERSTELLUNGSVERFAHREN DAFÜR[2023/02]
English:LIVE-PATHOGEN-MIMETIC NANOPARTICLES BASED ON PATHOGEN CELL WALL SKELETON, AND PRODUCTION METHOD THEREOF[2023/02]
French:NANOPARTICULES MIMÉTIQUES D'AGENT PATHOGÈNE VIVANT BASÉES SUR UN SQUELETTE DE PAROI CELLULAIRE D'AGENT PATHOGÈNE, ET LEUR PROCÉDÉ DE PRODUCTION[2023/02]
Entry into regional phase30.09.2022Translation filed 
30.09.2022National basic fee paid 
30.09.2022Search fee paid 
30.09.2022Designation fee(s) paid 
30.09.2022Examination fee paid 
Examination procedure30.09.2022Amendment by applicant (claims and/or description)
30.09.2022Examination requested  [2023/02]
Fees paidRenewal fee
15.02.2023Renewal fee patent year 03
19.02.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]EP3922266  (RESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV [KR]) [E] 1-17* figure 8; example 2 *;
 [X]  - NAKAMURA TAKASHI ET AL, "Nanoparticulation of BCG-CWS for application to bladder cancer therapy", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20131231), vol. 176, doi:10.1016/J.JCONREL.2013.12.027, ISSN 0168-3659, pages 44 - 53, XP028665634 [X] 1-17 * abstract * * page 45, column left, paragraph 2; figure 2 * * paragraph 2.2 * * paragraph 3.3;; figure 3 *

DOI:   http://dx.doi.org/10.1016/j.jconrel.2013.12.027
 [A]  - MASUDA HIDEYUKI ET AL, "Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology", MOLECULAR PHARMACEUTICS, US, (20181203), vol. 15, no. 12, doi:10.1021/acs.molpharmaceut.8b00919, ISSN 1543-8384, pages 5762 - 5771, XP093131679 [A] 1-17 * page 5764, column lect, paragraph 6; figure 8 *

DOI:   http://dx.doi.org/10.1021/acs.molpharmaceut.8b00919
 [A]  - PAIK T H ET AL, "Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 28, no. 50, ISSN 0264-410X, (20101123), pages 7873 - 7880, (20101123), XP027553549 [A] 1-17 * abstract * * paragraph 2.3 * * page 7874, column left, paragraph 2 *
 [A]  - DOWLING DAVID J., "Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants", IMMUNOHORIZONS, (20180701), vol. 2, no. 6, doi:10.4049/immunohorizons.1700063, pages 185 - 197, XP055895475 [A] 1-17 * page 1898, column left, paragraph 2 * * page 2; table 2 *

DOI:   http://dx.doi.org/10.4049/immunohorizons.1700063
 [A]  - BOB J. IGNACIO ET AL, "Toll-like Receptor Agonist Conjugation: A Chemical Perspective", BIOCONJUGATE CHEMISTRY, US, (20180129), vol. 29, no. 3, doi:10.1021/acs.bioconjchem.7b00808, ISSN 1043-1802, pages 587 - 603, XP055598375 [A] 1-17 * page 595, column right, paragraph 3 *

DOI:   http://dx.doi.org/10.1021/acs.bioconjchem.7b00808
 [T]  - JIN SEUNG MO ET AL, "A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion", NATURE NANOTECHNOLOGY, London, vol. 18, no. 4, doi:10.1038/s41565-022-01296-w, ISSN 1748-3387, (20230112), pages 390 - 402, URL: https://www.nature.com/articles/s41565-022-01296-w.pdf, XP093131527

DOI:   http://dx.doi.org/10.1038/s41565-022-01296-w
International search[A]KR20180093813  (DANDI BIOSCIENCE INC [KR]) [A] 1-20 * See abstract; and claims 1-17. *;
 [A]KR20190061741  (RESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV [KR]) [A] 1-20* See abstract; and claims 1-9. *;
 [A]  - Nakamura Takashi; Fukiage Masafumi; Higuchi Megumi; Nakaya Akihiro; Yano Ikuya; Miyazaki Jun; Nishiyama Hiroyuki; Akaza Hideyuki; Ito Toshihiro; Hosokawa Hiroyuki; Nakayama Toshinori; Harashima Hideyoshi, "Nanoparticulation of BCG-CWS for application to bladder cancer therapy", Journal of Controlled Release, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL, (20131231), vol. 176, doi:10.1016/j.jconrel.2013.12.027, ISSN 0168-3659, pages 44 - 53, XP028665634 [A] 6

DOI:   http://dx.doi.org/10.1016/j.jconrel.2013.12.027
by applicantWO2007024612
 WO2010014913
 WO2010054215
 US2010143301
 WO2010133885
 WO2011022508
 WO2011022509
 WO2011027022
 WO2011049677
 WO2011057148
 WO2012066335
 WO2012066336
 WO2012067268
 WO2012080730
 WO2012097177
 WO2012097173
 WO2012136834
 WO2012156498
 WO2013068438
 WO2013117615
 WO2013172479
 KR20140041134
 WO2014053516
 WO2014053595
 WO2014056593
 WO2014076221
 US8846697
 WO2014207082
 WO2015014815
 WO2015023598
 WO2016007765
 WO2016023511
 WO2016044182
 WO2016055553
 WO2016091698
 WO2016096778
 WO2016141092
 WO2016142250
 WO2016180691
 WO2016180743
 WO2017035230
 WO2017046112
 WO2017076346
 WO2017102652
 WO2017133683
 WO2017133686
 WO2017133684
 WO2017133687
 WO2017197624
 WO2017202704
 WO2017202703
 WO2017216054
 WO2017219931
 WO2018002319
 WO2018041763
 WO2018045144
 WO2018068593
 WO2018078149
 WO2018095426
 US2018215720
 WO2018196823
 CN108794486
 WO2018210298
 CN108948016
 WO2018233648
 WO2019036023
 WO2019035969
 WO2019035970
 WO2019035971
 WO2019035968
 WO2019040491
 KR20200025780
 KR20200097656
 KR20210026013
 WO2009US35563
 WO2015US28264
 WO2015US39776
 WO2016US20499
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.